Inflammatory Myopathy with Abundant Macrophages (IMAM)
Immune/AntibodyOMIM 123886
W
View full entry on WUSTL Neuromuscular
antibody/infmyop.htm#Inflammatory Myopathy with Abundant Macrophages (IMAM)
40
Overview
From WUSTL NeuromuscularClinical Onset Ages: Childhood to 78 years Progression: Days to Weeks Children Most commonly asymptomatic Skin Rash: May be similar to dermatomyositis Edema Muscle Weakness: Proximal; Mild to Marked Myalgias Systemic features (25%) Arthralgias Raynaud's Lung infiltrate Treatment Corticosteroids Other immunomodulation Course Remission in some: After immunomodulating treatment Death: Occasional; Multiple organ failure may occur Laboratory Serum CK: Normal or Mildly high Aldolase: May be high with normal CK Serum autoantibodies: No consistent pattern Muscle pathology Histiocyte (Macrophage) infla
OMIM Entries
External Resources
Data sourced from the Washington University Neuromuscular Disease Center. For clinical use, always refer to primary sources.